These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation. Malik M Drug Saf; 2016 Jul; 39(7):647-59. PubMed ID: 26968542 [TBL] [Abstract][Full Text] [Related]
5. Pro- and antiarrhythmic effects of ATP-sensitive potassium current activation on reentry during early afterdepolarization-mediated arrhythmias. Chang MG; de Lange E; Calmettes G; Garfinkel A; Qu Z; Weiss JN Heart Rhythm; 2013 Apr; 10(4):575-82. PubMed ID: 23246594 [TBL] [Abstract][Full Text] [Related]
6. Torsade de pointes with sotalol overdose treated successfully with lidocaine. Assimes TL; Malcolm I Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533 [TBL] [Abstract][Full Text] [Related]
7. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Shimizu W; Antzelevitch C Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813 [TBL] [Abstract][Full Text] [Related]
8. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias. Aizawa Y; Uchiyama H; Yamaura M; Nakayama T; Arita M J Electrocardiol; 1998 Apr; 31(2):117-23. PubMed ID: 9588657 [TBL] [Abstract][Full Text] [Related]
9. [Classification and treatment of torsades de pointes (TdP): a report of 11 cases]. Mei KZ; Sun AH; Li BJ Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):28-30. PubMed ID: 8404313 [TBL] [Abstract][Full Text] [Related]
10. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes. Kurita T; Ohe T; Shimizu W; Hotta D; Shimomura K Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):33-8. PubMed ID: 7681173 [TBL] [Abstract][Full Text] [Related]
11. Nicorandil, a potassium channel opener, abolished torsades de pointes in a patient with complete atrioventricular block. Watanabe O; Okumura T; Takeda H; Nakamura W; Segawa K; Ito H; Yoshimoto N Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):686-8. PubMed ID: 10234727 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Thomas SH; Behr ER Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037 [TBL] [Abstract][Full Text] [Related]